share_log

Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators

Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators

阿爾及利亞推出拉塞爾創新可交易ETF,以利用新興創新者的機會
Benzinga ·  01/09 03:32

On Tuesday, Alger launched the Alger Russell Innovation ETF (NYSE:INVN), another addition to its lineup of funds aiming to cash in on transformative market opportunities.

週二,阿爾及爾推出了阿爾及爾拉塞爾創新可交易ETF(紐交所:INVN),這是其爲抓住變革性市場機遇而增加的另一個基金。

The ETF comes with an expense ratio of 0.55% and mirrors the Alger Russell Innovation Index, which focuses on innovative underdogs with high potential. At least 80% of the fund's total assets are invested in securities of the Alger Russell Innovation Index, according to the fund's prospectus.

該ETF的費用比率爲0.55%,並與阿爾及爾拉塞爾創新指數相匹配,該指數專注於具有高潛力的創新型企業。根據基金的招募說明書,至少80%的基金總資產投資於阿爾及爾拉塞爾創新指數的證券。

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Teradata Corporation (NYSE:TDC), and Bristol-Myers Squibb Company (NYSE:BMY) are among the top holdings, accounting for 2.11%, 2.01%, and 2.03% as of Jan. 7. The fund's portfolio consists of about 50 holdings.

BioMarin製藥公司(納斯達克:BMRN)、Teradata公司(紐交所:TDC)和施貴寶公司(紐交所:BMY)是主要持股之一,截止1月7日,分別佔比2.11%、2.01%和2.03%。該基金的投資組合由大約50個持股組成。

The index uses a quantitative methodology to identify innovation-driven equities, shortlists them based on lower cash flow margins and then ranks them based on research and development expenditures. The top 50 companies on this ranking are then selected, with each stock constituting around 2% of the portfolio.

該指數採用定量方法識別創新驅動的股票,在較低現金流邊際的基礎上進行篩選,然後根據研發支出進行排名。排名前50的公司被選中,每隻股票在投資組合中約佔2%。

Brad Neuman, CFA, Alger's Director of Market Strategy, thinks that this approach could bring innovation "out of the shadow of financial statements" and into accessible investment instruments.

阿爾及爾市場策略董事Brad Neuman,CFA認爲這種方法可以將創新「擺脫基本報表的陰影」,轉向更可接觸的投資工具。

The launch of INVN makes it the sixth Alger ETF available on U.S. markets. Among its other offerings, the Alger Mid Cap 40 ETF (NYSE:FRTY) stands out with over $70 million in assets under management.

INVN的推出使其成爲在美國市場上可用的第六隻阿爾及爾ETF。在其其他產品中,阿爾及爾中型股40可交易ETF(紐交所:FRTY)以超過7000萬資產管理規模而脫穎而出。

  • Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
  • 禽流感引發生物-疫苗股票激增:隨着H5N1疫情加劇,值得關注的ETF

Photo: Shutterstock

Photo: Shutterstock

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論